Cutaneous adverse drug reactions in hospitalised patients

Singapore Medical Journal

Volumn 51, Issue 10, 2010, Pages 767-774

  Lee, H Y ^a   Tay, L K ^a   Thirumoorthy, T ^a   Pang, S M ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Cutaneous adverse drug reactions; Drug allergy; Drug hypersensitivity; Stevens johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CONTRAST MEDIUM; MEROPENEM; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TUBERCULOSTATIC AGENT;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADULT; ADVERSE DRUG REACTION; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DRESS SYNDROME; DRUG INDUCED DISEASE; EXFOLIATIVE DERMATITIS; FEMALE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SYSTEMIC DISEASE; TERTIARY HEALTH CARE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DERMATOLOGY; DRUG HYPERSENSITIVITY; EPIDERMAL NECROLYSIS, TOXIC; HOSPITALIZATION; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; SINGAPORE; SKIN; SKIN DISEASES; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME;

EID: 78649437515     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lazorou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998; 279:1200-1205.
2. Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48:839-846.
3. Bigby M, Jick S, Jick H, Arndt K. Drug induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1985. JAMA 1986; 256:3358-3363.
4. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Eng J Med 1994; 331:1272-1285.
5. Fong PH, Chan HL. Current cutaneous drug reaction patterns in Singapore. Singapore Med J 1984; 25:336-339.
6. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209:123-129.
7. Mockenhaupt M. Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. J Dtsch Dermatol Ges 2009; 7:142-160.
8. Barbaud A, Goncalo M, Brunzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45:321-328.
9. Bircher A. Approach to the patient with a drug hypersensitivity reaction - clinical perspective. In: Pichler WJ, ed. Drug hypersensitivity. Basel: Karger, 2007: 352-365.
10. Gruchalla RS, Pirmohamed M. Clinical practice. Antibiotic allergy. N Eng J Med 2006; 354:601-609.
11. Mirakian R, Ewan PW, Durham SR et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 2009; 39:43-61.
12. Barbaud A, Reichert-Penetrat S, Techot P, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139:49-58.
13. Romano A, Di Fonso M, Papa G, et al. Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes. Allergy 1995; 50:113-118.
14. Wolkenstein P, Chowsidow O, Flechet ML, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35:234-236.
15. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005; 152:968-974.
16. Waton J, Trechot P, Loss-Ayav C, Schmutz JL, Barbaud A. Negative predictive value of drug skin tests in investigating cutaneous adverse reactions. Br J Dermatol 2009; 160:786-794.
17. Brown R, Rother K, Artman H, et al. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 2009; 145:63-66.
18. Sekine N, Motokura T, Oki T, et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 2001; 285:1153-1154.
19. Garcia-Doval I, Le Cleach L, Bocquet H, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000; 136:323-327
20. Palmieri TL, Greenhalgh DG, Saffe JR et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002; 23:87-96.
21. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients: Adverse Drug Events Prevention Study Group. JAMA 1997; 227:307-311.
22. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45:301-308.
23. Health Sciences Authority. Adverse Drug Reaction News 2009. Vol 11. No. 2. Available at: www.hsa.gov.sg/publish/etc/medialib/ hsa_library/health_products_regulation/safety_information/ adr_news_bulletin.Par.75889.File.tmp/ADR_News_Aug2009_Vol11_No2.pdf.Accessed February 1, 2010.
24. Health Science Authority. Adverse Drug Reaction News 2009. Vo l 11. No. 3. Available at: www.hsa.gov.sg/publish/etc/medialib/hsa_library/health_products_regulation/safety_information/ adr_news_bulletin.Par.42163.File.tmp/ADR_News_Dec2009_Vol11_No3.pdf. Accessed February 1, 2010.
25. Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The Euro SCAR Study. J Invest Dermatol 2008; 128:35-44.
26. Lim YL, Thirumoorthy T. Serious cutaneous adverse reactions to traditional Chinese medicines. Singapore Med J 2005; 46:714-7.
27. Bastuji-Garin S, Rzany B, Stern RS et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993; 129:92-96.
28. Kauppinen K, Stubb S. Fixed eruptions: causative drugs and challenge tests. Br J Dermatol 1985; 112:575-578.
29. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and Drug hypersensitivity Syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15:250-257.
30. Beylot C, Doutre MS, Beylot-barry M. Acute generalized exanthematous pustulosis. Semin Cutan Med Surg 1996; 15:244-249.
31. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356:1255-1259.